Accretion Nutraveda IPO

Accretion Nutraveda Ltd, incorporated in 2021, is involved in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms. Its offerings include tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.

The company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets, including countries like Sri Lanka, Singapore, and the USA. Its product approach blends traditional Ayurvedic formulations with modern nutraceutical science, targeting areas such as liver health, women’s wellness, bone and joint care, cognitive support, and respiratory health.

Business Verticals

1. Domestic Sales & Merchant Exports (Loan License Basis): Contributed 96.62% of total revenue in FY 2024–25.

2. Direct Exports: Accounted for 38%, reflecting steady growth in international business.

Manufacturing Facility

The company has a manufacturing unit in Gujarat, covering approximately 10,763 sq. ft. The facility is equipped with modern infrastructure, including 13 air handling units, dedicated processing sections, and quality control systems.

It holds multiple certifications, such as GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certification, along with an FSSAI license, ensuring compliance with industry standards.

Competitive Strengths

• Backed by experienced promoters and leadership

• Wide and diversified product portfolio

• Strong focus on quality and compliance standards

• Established relationships with clients and suppliers

• Well-defined operational and management processes